High Katherine A 4
4 · CRISPR Therapeutics AG · Filed Jun 14, 2021
Insider Transaction Report
Form 4
High Katherine A
Director
Transactions
- Award
Stock Option (Right to Buy)
2021-06-10+10,000→ 10,000 totalExercise: $123.71Exp: 2031-06-10→ Common Shares (10,000 underlying)
Footnotes (1)
- [F1]This option was granted on June 10, 2021 with respect to 10,000 Common Shares with 100% of the shares vesting in 12 equal monthly installments beginning on June 30, 2021; provided that the last installment will vest on the earlier of (i) the one year anniversary of the date of grant or (ii) the date of the 2022 Annual General Meeting of Shareholders.